Dishman Carbogen Amcis climbs 4% on demand of OFS for non-retail investors

The company’s Offer for Sale for non-retail investors gets demand for 66.8 lakh shares as compared to the 54.6 lakh on offer.

Jan 13, 2021 10:01 IST India Infoline News Service

Dishman Pharmaceuticals
Dishman Carbogen Amcis Limited Offer for Sale (OFS) for non-retail investors gets demand for 66.8 lakh shares as compared to the 54.6 lakh on offer.

the company stock was bullish during morning trade on Wednesday. At around 10.53 am, Dishman Carbogen Amcis Limited stock was trading at Rs146.70 up Rs5.45 or 3.86% on the BSE. The stock touched a high of Rs148 so far during intraday trade on Wednesday.

Bids were received at an indicative price of Rs140.11 per share. Further, the company will exercise the Oversubscription Option to the extent of 32.1 lakh equity shares, in addition to the Base Offer Size. Accordingly, the total Offer Size will now be 92.8 lakh equity shares representing 5.92% of the total paid up equity share capital of the company. The OFS for retail investors opens for subscription today.

“The company wished to exercise Oversubscription Option to the extent of 32,14,286 Equity Shares in addition to the Base Offer Size. Accordingly, the total Offer Size will be 92,85,715 Equity Shares representing 5.92% of the total paid up equity share capital of the company as on December 31, 2020,” company shared Adimans Technologies LLP (seller) release in a regulatory filing on Tuesday.

Related Story

Open Free Demat Account (Rs699)